Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products
Human Gene Therapy Methods · 2017-08 · 28 (4) · 205-214
DOI: 10.1089/hgtb.2017.078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy Methods, 2017-08. Verfasst von Yuan Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1 Division of Advanced Therapies, National Institute for Biological Standards and Control (NIBSC) , Medicines and Health Products Regulatory Agency (…. Hauptthemen laut MEDLINE: World Health Organization. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1 Division of Advanced Therapies, National Institute for Biological Standards and Control (NIBSC) , Medicines and Health Products Regulatory Agency (MHRA), South Mimms, United Kingdom .
- 2 Twincore Centre for Experimental and Clinical Infection Research , Hannover, Germany .
Förderung
- Department of Health
Zitieren
APA
Zhao, Y., Stepto, H., & Schneider, C. K. (2017). Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products. Human Gene Therapy Methods, 28(4), 205-214. https://doi.org/10.1089/hgtb.2017.078
Vancouver
Zhao Y, Stepto H, Schneider CK. Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products. Human Gene Therapy Methods. 2017;28(4):205-214. doi:10.1089/hgtb.2017.078
BibTeX
@article{Zhao2017,
author = {Zhao, Yuan and Stepto, Hannah and Schneider, Christian K},
title = {Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products},
journal = {Human Gene Therapy Methods},
year = {2017},
volume = {28},
number = {4},
pages = {205--214},
doi = {10.1089/hgtb.2017.078}
}
EUVIMED